Suzanne Ildstad, Chief Scientific Officer at Talaris Therapeutics, Inc. (TALS), sold 525,000 shares at $2.80 ($1.5M) on 2022-08-22, disclosed to the SEC on 2022-08-23.
Open-market sale of $1.5M TALS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TALS | SELL | 2023-06-07 | $149K | — | Filing → |
| TALS | SELL | 2023-06-05 | $80K | — | Filing → |
| TALS | SELL | 2023-04-25 | $35K | — | Filing → |